Whether it’s developing a PopPK or PD model, conducting an exposure response analysis, or providing any other types of pharmacometrics support, our team of pharmacometricians, modelers, and analysts have you covered!
Interesting Key Facts
We are experienced clinical pharmacologists with broad drug development experience.
We have extensive regulatory interaction experience with all major global health authorities. In addition, we have tremendous risk assessment based due diligence as well as co-development experience.
-
100+
Pre - IND
Meetings -
120+
ORIGINAL INDs &
IMPDs -
20+
EoP1 & EoP2
Meetings -
40+
Due Diligences & Collaborations
with VCs on Due Diligences -
80+
Clients
-
800+
PK Analysis